.png)
JHVEPhoto/iStock Editorial via Getty Images
Novo Nordisk (NVO) (OTCPK:NONOF) appears to have forced its CEO, Lars Fruergaard Jørgensen, to resign as the Danish pharma giant grapples with the rising dominance of its U.S. rival, Eli Lilly (NYSE:LLY), and makers of
English (US) ·